IISc Bengaluru launches admission portal for JAM 2021 exams; registration to start from 10 Sept

-

The Indian Institute of Science Bengaluru (IISc Bengaluru) has announced the dates for JAM 2021. The registration process for JAM 2021 will commence from 10 September.

The application form for JAM 2021 will only be available online on the official website jam.iisc.ac.in. The last date to fill the application form is 15 October.

The exam will be conducted on 14 February and the results will be announced on 20 March.

Apart from Mathematics, Chemistry, Physics, Biotechnology, Geology and Mathematical Statistics, the admission test will also include Economics, reported NDTV.

The test will be conducted in a computer-based mode and will be held in two shifts.

JAM is an all-India based examination jointly conducted by the Indian Institiutes of Technology and Indian Institute of Science. It is held for admission to MSc (Two year course), Joint MSc-PhD, MSc-PhD Dual Degree and other Post-Bachelor's Degree programmes at the IITs and to the Integrated PhD programmes at IISc.

JAM is conducted in eight zones jointly by Indian Institute of Science (IISc), Bengaluru, and seven Indian Institutes of Technology. These include centres at Delhi, Mumbai, Guwahati, Kanpur, Kharagpur, Madras and Roorkee. It is held on behalf of Ministry of Education (MoE).

As per the JAM website (jam.iisc.ac.in), admissions to various academic programmes at IITs for the Academic Session 2021-22 will be made based on the All India merit list of JAM 2021.

Candidates who qualify for the test paper will be eligible to apply for admission to all the academic programmes corresponding to that test paper only if they satisfy minimum educational qualifications and eligibility requirements as specified by the concerned institutes.

Once results are declared, qualified candidates have to apply online at JAM Online Application Processing System (JOAPS) through IISc Bangalore, specifying preferences for programmes of their interest.



from Firstpost India Latest News https://ift.tt/2F4jgL4
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more